Rapid Growth of Memory ETF Highlights AI Chip Bottleneck Prediction Markets Signal Rising Probability of Fed Rate Hike by July 2027 Perpetua Resources Secures 29 Billion US Loan for Idaho GoldAntimony Project Jim Cramer Delivers Market Commentary in Latest Morning Meeting Nvidia Stock Approaches Critical Technical Level as Traders Watch for Direction IPO Calendar Three Companies Set to Launch Public Offers Amid Market Volatility VST Q1 2026 Earnings Massive EPS Surprise Drives Stock Rally 374Water Inc SCWO Q1 2026 Earnings Net Loss Widens as Development Continues Without Revenue CCEP Q4 2018 Earnings Modest EPS Miss Amidst Quiet Quarter Saratoga Investment Corp SAY Q1 2026 Earnings Significant EPS Miss Despite Slight Stock Uptick Astec Industries Q1 2026 Earnings EPS Misses Estimates Amid Challenging Conditions HOMB Q1 2026 Earnings EPS Slightly Misses Estimate Shares Modestly Higher Muzero Acquisition Corp Warrant MUZEW Holds Steady at 028 With Tight Trading Range High Income Securities Fund PCF Holds Steady Near Support Amid Low Volatility Cayson Acquisition Corp CAPN Holds Steady at 1078 Amid Low Volume Potential Support and Resistance Levels to Watch Eaton Vance TaxManaged BuyWrite Income Fund ETB Holds Steady With Modest Gain as Income Strategy Remains in Focus Palvella Therapeutics PVLA Gains 2 as Stock Approaches Key Resistance Level Trump Skips Sons Wedding Citing Iran Concerns Geopolitical Focus May Shape Market Sentiment CACI Q1 2026 Earnings Earnings Beat Drives Modest Stock Uptick Zscaler Plunges Over 31 Key Support and Resistance Levels for ZS Stock JIADE LIMITED JDZG Shows Renewed Momentum Testing Key Resistance Levels Gores Holdings X GTENU Inches Higher as SPAC Unit Nears Key Resistance Western Asset High Income Fund II HIX Edges Lower as Yield Seekers Navigate Bond Market Uncertainty Procter Gamble PG Edges Higher Resilience in a Shifting Consumer Landscape Addex Therapeutics ADXN Holds Gains Amid Biotech Sector Momentum Enova International ENVA Declines 175 as Stock Holds Between Key Support and Resistance Immunovant IMVT Holds Steady Near Support as Biotech Sector Faces Headwinds